Pricing
Login
Home
Charts
Search
Watchlist
Products

Mankind Pharma Ltd

MANKIND
₹2,665.00+1.37%20 Nov 2026
Reports
Pharma Formulations

Mankind Pharma Ltd

MANKIND
₹2,665.00
+1.37%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,10,077Cr
Close
Close Price
₹2,665.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
49.05
PS
Price To Sales
7.16
Revenue
Revenue
₹15,379Cr
Rev Gr TTM
Revenue Growth TTM
13.53%
PAT Gr TTM
PAT Growth TTM
27.60%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,6072,4222,8683,0613,1993,0793,5703,6973,5673,4434,0314,338
Growth YoY
Revenue Growth YoY%
24.718.011.213.122.727.124.520.811.511.812.917.3
Expenses
ExpensesCr
2,0001,8362,1962,2142,3832,3962,7242,7762,6482,5132,9743,167
Operating Profit
Operating ProfitCr
6075866728478166838479219199301,0561,171
OPM
OPM%
23.324.223.427.725.522.223.724.925.827.026.227.0
Other Income
Other IncomeCr
7595103112802548394-31944999
Interest Expense
Interest ExpenseCr
99117221191171170157142110105
Depreciation
DepreciationCr
110100103100187231219222223223226236
PBT
PBTCr
562572661851488515540624509659769929
Tax
TaxCr
10395123190110869610495100195213
PAT
PATCr
460477543659385425445520414559574716
Growth YoY
PAT Growth YoY%
55.562.39.928.9-16.4-10.9-18.1-21.17.631.729.137.7
NPM
NPM%
17.619.718.921.512.013.812.414.111.616.314.216.5
EPS
EPS₹
11.311.813.416.39.510.210.612.49.913.413.817.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,6072,4222,8683,0613,1993,0793,5703,6973,5673,4434,0314,338
Growth YoY
Revenue Growth YoY%
24.718.011.213.122.727.124.520.811.511.812.917.3
Expenses
ExpensesCr
2,0001,8362,1962,2142,3832,3962,7242,7762,6482,5132,9743,167
Operating Profit
Operating ProfitCr
6075866728478166838479219199301,0561,171
OPM
OPM%
23.324.223.427.725.522.223.724.925.827.026.227.0
Other Income
Other IncomeCr
7595103112802548394-31944999
Interest Expense
Interest ExpenseCr
99117221191171170157142110105
Depreciation
DepreciationCr
110100103100187231219222223223226236
PBT
PBTCr
562572661851488515540624509659769929
Tax
TaxCr
10395123190110869610495100195213
PAT
PATCr
460477543659385425445520414559574716
Growth YoY
PAT Growth YoY%
55.562.39.928.9-16.4-10.9-18.1-21.17.631.729.137.7
NPM
NPM%
17.619.718.921.512.013.812.414.111.616.314.216.5
EPS
EPS₹
11.311.813.416.39.510.210.612.49.913.413.817.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5,8656,2147,7828,74910,26012,20714,27815,379
Growth
Revenue Growth%
6.025.212.417.319.017.013.5
Expenses
ExpensesCr
4,4284,5665,7926,8497,7479,19010,66011,302
Operating Profit
Operating ProfitCr
1,4371,6481,9891,9012,5143,0183,6174,077
OPM
OPM%
24.526.525.621.724.524.725.326.5
Other Income
Other IncomeCr
122183210141295549241211
Interest Expense
Interest ExpenseCr
2220594433429639514
Depreciation
DepreciationCr
99119167326378621886907
PBT
PBTCr
1,4381,6921,9751,6712,3982,5162,3332,867
Tax
TaxCr
382399522362457510395603
PAT
PATCr
1,0561,2931,4531,3101,9412,0071,9382,264
Growth
PAT Growth%
22.412.4-9.948.23.4-3.427.6
NPM
NPM%
18.020.818.715.018.916.413.614.7
EPS
EPS₹
25.731.635.832.047.849.346.454.3
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5,8656,2147,7828,74910,26012,20714,27815,379
Growth
Revenue Growth%
6.025.212.417.319.017.013.5
Expenses
ExpensesCr
4,4284,5665,7926,8497,7479,19010,66011,302
Operating Profit
Operating ProfitCr
1,4371,6481,9891,9012,5143,0183,6174,077
OPM
OPM%
24.526.525.621.724.524.725.326.5
Other Income
Other IncomeCr
122183210141295549241211
Interest Expense
Interest ExpenseCr
2220594433429639514
Depreciation
DepreciationCr
99119167326378621886907
PBT
PBTCr
1,4381,6921,9751,6712,3982,5162,3332,867
Tax
TaxCr
382399522362457510395603
PAT
PATCr
1,0561,2931,4531,3101,9412,0071,9382,264
Growth
PAT Growth%
22.412.4-9.948.23.4-3.427.6
NPM
NPM%
18.020.818.715.018.916.413.614.7
EPS
EPS₹
25.731.635.832.047.849.346.454.3
Sales CAGR
1 Year17%
3 Years18%
5 Years18%
TTM14%
EBITDA CAGR
1 Year20%
3 Years24%
5 Years17%
TTM25%
PAT CAGR
1 Year-3%
3 Years14%
5 Years8%
TTM28%
Avg. ROCE
1 Year13%
3 Years17%
5 Years21%
TTM15%
CFO / EBITDA
1 Year86%
3 Years84%
5 Years80%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
4040404040414141
Reserves
ReservesCr
3,4454,6826,1157,3959,32314,29116,25917,541
Current Liabilities
Current LiabilitiesCr
1,2591,3532,6231,8632,1205,6646,5075,885
Non Current Liabilities
Non Current LiabilitiesCr
1431562082292687,5285,0115,214
Total Liabilities
Total LiabilitiesCr
5,0736,3739,1489,71511,96327,76028,08028,954
Current Assets
Current AssetsCr
2,8223,9074,4074,3286,5686,9886,9547,956
Non Current Assets
Non Current AssetsCr
2,2512,4664,7415,3885,39520,77121,12520,998
Total Assets
Total AssetsCr
5,0736,3739,1489,71511,96327,76028,08028,954
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
4040404040414141
Reserves
ReservesCr
3,4454,6826,1157,3959,32314,29116,25917,541
Current Liabilities
Current LiabilitiesCr
1,2591,3532,6231,8632,1205,6646,5075,885
Non Current Liabilities
Non Current LiabilitiesCr
1431562082292687,5285,0115,214
Total Liabilities
Total LiabilitiesCr
5,0736,3739,1489,71511,96327,76028,08028,954
Current Assets
Current AssetsCr
2,8223,9074,4074,3286,5686,9886,9547,956
Non Current Assets
Non Current AssetsCr
2,2512,4664,7415,3885,39520,77121,12520,998
Total Assets
Total AssetsCr
5,0736,3739,1489,71511,96327,76028,08028,954

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0701,1379201,8132,1522,4133,121
Investing Cash Flow
Investing Cash FlowCr
-439-1,222-1,369-1,054-2,082-12,683-196
Financing Cash Flow
Financing Cash FlowCr
-531-8605-740510,233-2,953
Net Cash Flow
Net Cash FlowCr
100-931551976-37-28
Free Cash Flow
Free Cash FlowCr
8788334581,0301,8451,9652,498
CFO To PAT
CFO To PAT%
101.388.063.3138.4110.9120.3161.1
CFO To EBITDA
CFO To EBITDA%
74.569.046.295.485.680.086.3
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1,0701,1379201,8132,1522,4133,121
Investing Cash Flow
Investing Cash FlowCr
-439-1,222-1,369-1,054-2,082-12,683-196
Financing Cash Flow
Financing Cash FlowCr
-531-8605-740510,233-2,953
Net Cash Flow
Net Cash FlowCr
100-931551976-37-28
Free Cash Flow
Free Cash FlowCr
8788334581,0301,8451,9652,498
CFO To PAT
CFO To PAT%
101.388.063.3138.4110.9120.3161.1
CFO To EBITDA
CFO To EBITDA%
74.569.046.295.485.680.086.3

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
92,02999,97482,8071,10,077
Price To Earnings
Price To Earnings
48.150.21.149.0
Price To Sales
Price To Sales
9.08.25.87.2
Price To Book
Price To Book
9.87.00.16.3
EV To EBITDA
EV To EBITDA
36.435.824.528.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
65.168.566.163.966.068.168.268.2
OPM
OPM%
24.526.525.621.724.524.725.326.5
NPM
NPM%
18.020.818.715.018.916.413.614.7
ROCE
ROCE%
40.434.528.922.625.412.913.114.8
ROE
ROE%
30.327.423.617.620.714.011.912.9
ROA
ROA%
20.820.315.913.516.27.26.97.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
92,02999,97482,8071,10,077
Price To Earnings
Price To Earnings
48.150.21.149.0
Price To Sales
Price To Sales
9.08.25.87.2
Price To Book
Price To Book
9.87.00.16.3
EV To EBITDA
EV To EBITDA
36.435.824.528.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
65.168.566.163.966.068.168.268.2
OPM
OPM%
24.526.525.621.724.524.725.326.5
NPM
NPM%
18.020.818.715.018.916.413.614.7
ROCE
ROCE%
40.434.528.922.625.412.913.114.8
ROE
ROE%
30.327.423.617.620.714.011.912.9
ROA
ROA%
20.820.315.913.516.27.26.97.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,19,7001,16,1191,14,3161,10,0771,03,51092,09974,733
Close PriceClose₹1,200.001,390.201,415.002,665.001,799.002,014.002,648.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE28.6741.3639.4549.0526.0917.2451.49
Price To SalesPS3.943.514.067.162.803.004.69
RevenueRevenueCr30,37833,09728,13915,37936,91330,74615,937
Revenue Growth TTMRev Gr TTM%24.0%-3.5%-0.7%13.5%13.5%24.2%-0.1%
PAT Growth TTMPAT Gr TTM%-14.6%-51.9%-47.4%27.6%16.5%20.1%43.7%
Market CapitalizationMkt CapCr1,19,7001,16,1191,14,3161,10,0771,03,51092,09974,733
Close PriceClose₹1,200.001,390.201,415.002,665.001,799.002,014.002,648.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE28.6741.3639.4549.0526.0917.2451.49
Price To SalesPS3.943.514.067.162.803.004.69
RevenueRevenueCr30,37833,09728,13915,37936,91330,74615,937
Revenue Growth TTMRev Gr TTM%24.0%-3.5%-0.7%13.5%13.5%24.2%-0.1%
PAT Growth TTMPAT Gr TTM%-14.6%-51.9%-47.4%27.6%16.5%20.1%43.7%